Doctors do not have to prescribe generic drugs. Instead, they are motivated by Health Insurance to prescribe drugs with an International Nonproprietary Name (INN), that is, by specifying the name of the molecule.
From 2015, this type of prescription should be mandatory in France: doctors will not prescribe the originator, but the molecule.
If the patient prefers not to take generic drugs, the doctor may indicate on the prescription "non-substitutable". In this case, the reasons can only hold to the patient himself, they are related to his interest. The pharmacist can not then deliver generic drugs during the delivery of the treatment.
The agreement that was put in place with the Health Insurance Fund requires pharmacists to deliver the generic medicine so that the patient can benefit from the third-party payment .
That is, if the patient refuses to take the generic drug, the pharmacists are obliged to charge the patient the entire treatment. Then, the patient will send the sheet of care to Social Security for reimbursement.
Generic drugs in Europe
In general, generic drugs are more widely used in other European countries by
in France, Germany, Great Britain, Holland ... but also in other countries like Canada or the United States.
All European countries are developing generic medicines because they are as safe and effective as the originator medicines and have the advantage of coping with the explosion of health expenditure, while we are in a very difficult crisis to manage by governments.
The price of generic drugs is lower, which saves money on health costs while allowing access to care for all patients. Generic medicines are primarily medicines subject to the same controls as the originators, which contribute to quality medication.